SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
PeerJ · 2025
DOI: 10.7717/peerj.19651 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PeerJ, 2025. Verfasst von Marlon Yuri Garcia-Paitan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell Culture and Immunology Lab, Universidad Cientifica del Sur, Lima, Peru. Hauptthemen laut MEDLINE: Immunity, Cellular, COVID-19, Immunity, Humoral, SARS-CoV-2. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PROCIENCIA-AECID, Universidad Científica del Sur.
Abstract (Originalsprache)
Background
Evaluating both humoral and cellular immunity is essential for optimizing vaccination strategies and preventing post-pandemic SARS-CoV-2 outbreaks. This cross-sectional study assessed cellular immunity by measuring CXCL10 mRNA expression and humoral immunity through SARS-CoV-2-specific IgG antibodies.
Method
Whole blood samples were collected from 40 Peruvian volunteers. CXCL10 expression was evaluated in blood samples stimulated with Spike protein peptides from the Wuhan strain and Omicron BA.5 variant using RT-qPCR. Anti-spike IgG levels were measured with a semi-quantitative ELISA.
Results
The median age was 31 years, with 62.5% females. A heterologous vaccination scheme was reported by 73%, but only 25% received their last dose within the past 6 months, and 55% completed three doses. The BNT162b2 vaccine was included in 88% of vaccination schemes, serving as the first and second dose in 48% of cases. All participants had detectable anti-spike IgG antibodies; 90% exhibited cellular responses to Wuhan peptides and 97.5% to Omicron peptides. CXCL10 mRNA expression (2 −ΔΔCT ) was significantly higher for Omicron (median: 565.97; IQR: 565,148.34) compared to Wuhan (median: 18.55; IQR: 62,898.67). Higher anti-spike IgG levels correlated with age and the number of vaccine doses. Males had significantly higher CXCL10 and anti-spike IgG levels ( p < 0.05). Antibody levels were greater in those recently boosted or vaccinated with mRNA-1273 ( p = 0.001, p = 0.002).
Conclusion
Most participants exhibited robust immunity, characterized by elevated levels of CXCL10 and anti-SARS-CoV-2 IgG antibodies. These findings highlight the importance of boosters in enhancing immunity and the need for diverse techniques for measuring immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Culture and Immunology Lab, Universidad Cientifica del Sur, Lima, Peru.
- Cancer and Stem Cells Research Group, Universidad Cientifica del Sur, Lima, Peru.
- Unidad de Posgrado de la Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima, Peru.
- Grupo de Enfermedades Infecciosas Re-Emergentes, Universidad Cientifica del Sur, Lima, Lima, Peru.
ORCID-Profile: Marlon Yuri Garcia-Paitan, Maria J Pons
Förderung
- PROCIENCIA-AECID
- Universidad Científica del Sur
Zitieren
APA
Garcia-Paitan, M. Y., Tapia-Rojas, S., Alvarez Vega, H. S., Enciso-Benavides, J., Pons, M. J., & Mayanga-Herrera, A. (2025). SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study. PeerJ. https://doi.org/10.7717/peerj.19651
Vancouver
Garcia-Paitan MY, Tapia-Rojas S, Alvarez Vega HS, Enciso-Benavides J, Pons MJ, Mayanga-Herrera A. SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study. PeerJ. 2025. doi:10.7717/peerj.19651
BibTeX
@article{GarciaPaitan2025,
author = {Garcia-Paitan, Marlon Yuri and Tapia-Rojas, Salyoc and Alvarez Vega, Hector Santiago and Enciso-Benavides, Javier and Pons, Maria J and Mayanga-Herrera, Ana},
title = {SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19651}
}
EUVIMED